Coty Inc
9 nominees · 3 ballot items.
The 2025 Coty proxy includes three matters for a vote: election of nine director nominees, advisory Say-on-Pay on named executive officer compensation, and ratification of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
Follow how the vote landed and what changed on Coty Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of the nine director nominees named in the proxy statement to serve until the next annual meeting.
- 2
Approval of Advisory Resolution on Named Executive Officer Compensation (Say-On-Pay
ManagementBoard: FORAdvisory vote to approve the compensation of Coty’s named executive officers as disclosed in the proxy materials.
- 3
Ratification of the Appointment of Deloitte & Touche LLP as Our Independent Registered Public Accounting Firm
ManagementBoard: FORRatify Deloitte & Touche LLP as Coty’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
Nominees on the ballot9
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BNP PARIBAS FINANCIAL MARKETS | 3.4% | 29,601,984 | $59M |
| 2 | Banco Santander, S.A. | 2.6% | 23,112,758 | $46M |
| 3 | BlackRock, Inc. | 2.3% | 20,071,030 | $40M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.3% | 19,857,339 | $40M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8% | 15,987,046 | $32M |
| 6 | CREDIT AGRICOLE S A | 1.8% | 15,610,163 | $31M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 1.4% | 12,144,675 | $24M |
| 8 | STATE STREET CORP | 1.3% | 11,241,409 | $23M |
| 9 | D. E. Shaw Co., Inc.Activist | 1.2% | 10,984,690 | $22M |
| 10 | BlackRock, Inc. | 1.2% | 10,722,553 | $22M |
Other Consumer Defensive sector meetings6
Upcoming shareholder meetings at Coty Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Coty Inc 2025 annual meeting?
- Coty Inc (COTY) holds its 2025 annual shareholder meeting on Thursday, November 6, 2025.
- What is the record date for the Coty Inc 2025 meeting?
- The record date for the Coty Inc 2025 meeting is Friday, September 12, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Coty Inc's 2025 meeting?
- The board is presenting 9 director nominees at the Coty Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Coty Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Coty Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.